Streetbeat News

Earnings

EXPI

eXp World Holdings shares are trading higher following the announcement of better-than-expected Q1 financial results.

Portfolio Pulse from Benzinga Newsdesk

May 02, 2024 | 5:07 pm

PH

Parker-Hannifin Corp (NYSE:PH) reported a slight increase in third-quarter fiscal 2024 sales to $5.07 billion, surpassing consensus estimates. Adjusted EPS rose to $6.51, beating expectations. The company saw mixed results in orders across its segments but experienced significant growth in the Aerospace Systems Segment. Operating cash flow and margins improved, leading to an upward revision of its fiscal 2024 outlook, including a raised adjusted EPS forecast and sales growth. Despite these positive results, PH shares dropped by 2.77%.

Portfolio Pulse from Akanksha Bakshi

May 02, 2024 | 5:06 pm

DBD

Diebold Nixdorf's shares surged following the announcement of their Q1 revenue results, which exceeded market expectations.

Portfolio Pulse from Benzinga Newsdesk

May 02, 2024 | 5:04 pm

MAX

MediaAlpha's shares surged following the announcement of Q1 financial results that exceeded expectations. Additionally, JP Morgan upheld an Overweight rating on the stock, increasing the price target from $18 to $30.

Portfolio Pulse from Benzinga Newsdesk

May 02, 2024 | 5:03 pm

MGM

Analyst ratings for MGM Resorts Intl (NYSE:MGM) show a diverse range of perspectives, with recent updates indicating a generally positive outlook. The average 12-month price target for MGM has increased to $55.00, up 7.23% from $51.29, with ratings ranging from 'Overweight' to 'Buy' and price targets adjusting upwards. MGM's financial performance is strong, with significant revenue growth, high net margin, and robust ROE and ROA, despite a high debt-to-equity ratio. The company's dominant position in the Las Vegas Strip and expanding operations, including U.S. sports and iGaming, contribute to its positive assessment.

Portfolio Pulse from Benzinga Insights

May 02, 2024 | 5:00 pm

CLMB

Climb Global Solutions shares are trading lower following the announcement of worse-than-expected Q1 financial results.

Portfolio Pulse from Benzinga Newsdesk

May 02, 2024 | 5:00 pm

VGR

Vector Group shares are trading lower following the announcement of worse-than-expected Q1 financial results.

Portfolio Pulse from Benzinga Newsdesk

May 02, 2024 | 5:00 pm

HDSN

Hudson Technologies' stock trades lower following Q1 financial results and a downgrade by Canaccord Genuity from Buy to Hold, with a price target reduction from $15 to $10.

Portfolio Pulse from Benzinga Newsdesk

May 02, 2024 | 4:57 pm

MCS

Marcus Corporation's shares declined following the announcement of their Q1 financial results.

Portfolio Pulse from Benzinga Newsdesk

May 02, 2024 | 4:56 pm

MRK

MRNA

Merck & Co Inc (NYSE:MRK) reported positive Phase III trial results for its gastric cancer treatment, showing significant improvement with its Keytruda regimen. The company also reported strong Q1 results, with a 9% YoY revenue increase to $15.78 billion, driven by Keytruda and vaccine sales. Despite the upcoming Keytruda patent expiration in 2028, Merck is preparing with new deals and drug launches, including a promising collaboration with Moderna Inc (NASDAQ:MRNA) on a melanoma treatment using mRNA technology.

Portfolio Pulse from Upwallstreet

May 02, 2024 | 4:53 pm